Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013

To SEC-MALS & Beyond - The Road to Biotherapeutic Development Illuminated by Light Scattering

01 Oct 2013 - 01 Oct 2013 - Online Webinar

Bookmark and Share

We present HPLC/SEC-MALS, the technique for quantifying absolute molecular weight, size, polydispersity, aggregation and degree of conjugation. Developers of biopharmaceuticals rely on Wyatt Technology's SEC-MALS products to navigate the path to drug product with confidence.  We review how the Wyatt light scattering instruments constitute a unique set of orthogonal and complementary methods alongside SEC-MALS: SEC-DLS for size & conformation; FFF-MALS for separation & characterization; CG-MALS for intermolecular interactions, and microwell plate-based DLS for high-throughput screening.

Who should attend:
• Researchers assessing biomolecular quality, including size and concentration of aggregates, degree of polymer conjugation, and column interactions
• Protein chemists optimizing production, modification, and formulation of biotherapeutic lead molecules
• Laboratory Managers/Directors/Supervisors performing biophysical characterization

Questions to be answered:
• How do MALS and DLS increase the chromatography data value for advanced analysis of IgG, ADCs, PEGylated proteins, and new format biotherapeutics?
• How can batch light scattering contribute to assessing stability and developing robust formulations?

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Batten Disease may Benefit from Gene Therapy
NIH-funded animal study suggests one-shot approach to injecting genes.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos